Birgitte Giersing

Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for <i>Plasmodium falciparum</i> Malaria

Elissa Malkin, David Diemert, Julie H. McArthur et al. · Infection and Immunity · 2005 · 251 citations · Full text

Vaccination, Asexual Blood-stage Vaccine, Vaccine Development +14

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

Kayvon Modjarrad, Birgitte Giersing, David C. Kaslow et al. · Vaccine · 2015 · 202 citations · Full text

Respiratory Virus Immunity, Respiratory Complications, Vaccine Hesitancy +16

UPDATE ON THE CLINICAL DEVELOPMENT OF CANDIDATE MALARIA VACCINES

W. Ripley Ballou, Myriam Arévalo‐Herrera, Daniel J. Carucci et al. · American Journal of Tropical Medicine and Hygiene · 2004 · 137 citations

Vaccination, Vaccine Safety, Malaria Vaccine Development +13

Montanide® ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations

Aaron P. Miles, Holly McClellan, Kelly M. Rausch et al. · Vaccine · 2004 · 99 citations

Vaccination, Vaccine Development, Vaccine Formulations +9

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

James F. Cummings, Michele Spring, Robert Schwenk et al. · Vaccine · 2009 · 88 citations

Malaria, Immune Regulation, Immunology +10